Adirna Therapeutics is a startup based in the United States.
Adirna Therapeutics is a company headquartered in the United States.
Adirna Therapeutics develops RNA-based precision medicines by targeting non-coding regions of the genome using AI-driven target discovery and therapeutic development platforms.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.